Cytogenetics findings in a histiocytic sarcoma case.

Area of Science:

• Oncology
• Hematology
• Cytogenetics

Background:

• Histiocytic sarcoma (HS) is a rare neoplasm originating from histiocytes.
• Diagnostic clarity for HS has improved with immunohistochemistry, but genetic insights remain limited.
• Understanding the genetic landscape of HS is crucial for diagnosis and treatment.

Purpose of the Study:

• To report a unique case of histiocytic sarcoma with novel cytogenetic findings.
• To characterize the immunohistochemical and cytogenetic profile of HS in a patient's bone marrow.
• To contribute to the limited knowledge of genetic alterations in histiocytic sarcoma.

Main Methods:

• Bone marrow biopsy and aspirate analysis.
• Immunohistochemical staining for lineage-specific markers (CD68, CD4, CD45).
• Cytogenetic analysis to identify chromosomal abnormalities and clonal evolution.

Main Results:

• The patient presented with bone marrow infiltration by monomorphic neoplastic cells.
• Immunohistochemistry revealed a profile of CD68(+), CD4(+), CD45(+).
• Cytogenetic studies identified four related clones with trisomy 8, tetrasomy 8, add(4)(p16), del(3)(q11), and t(3;5)(q25;q35).

Conclusions:

• This is the first reported case of histiocytic sarcoma exhibiting both trisomy and tetrasomy of chromosome 8.
• The identified chromosomal alterations represent a unique genetic signature for this HS case.
• Further research into these genetic abnormalities may offer new diagnostic and therapeutic avenues for HS.